切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - 5-HT7 Receptors - ULK1 - MAPKAP-K2 - Proteasome

19件产品中的 1-10

页面
每页
清除全部
  1. VR23
    B6026 VR23
    Target: Proteasome
    Summary: 蛋白酶抑制剂
      ≥45.55 mg/mL
      insoluble in H2O
  2. SBI-0206965
    A8715 SBI-0206965
     2 Citation
    Target: ULK1
    Summary: ULK1抑制剂
      ≥24.47 mg/mL
      insoluble in H2O
  3. Rottlerin
    B6803 Rottlerin
     1 Citation
    中文名: 揪毒素
    Target: PKC|Ca2 /calmodulin-dependent protein kinases (CaMKs)|PRAK|MAPKAP-K2
    Summary: PKC抑制剂
      ≥23.6 mg/mL
      insoluble in H2O
  4. Lurasidone HCl
    B1477 Lurasidone HCl
    中文名: 盐酸鲁拉西酮
    Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺D2/5-HT2A/5-HT7/5-HT1A抑制剂
      ≥11.11 mg/mL
      insoluble in H2O
  5. Quetiapine Fumarate
    B1490 Quetiapine Fumarate
     1 Citation
    中文名: 富马酸奎硫平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺受体拮抗剂
      ≥11.03 mg/mL
      insoluble in H2O
  6. PYR-41
    B1492 PYR-41
     2 Citation
    Target: Proteasome
    Summary: 泛素活化酶(E1)抑制剂
      ≥18.55 mg/mL
      insoluble in H2O
  7. Vortioxetine
    A3926 Vortioxetine
    中文名: 沃替西汀
    Target: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERT
    Summary: 5-HT受体拮抗剂
      ≥14.92 mg/mL
      insoluble in H2O
  8. AM 114
    A8163 AM 114
     2 Citation
    Target: Proteasome
    Summary: 20S蛋白酶体抑制剂
      ≥16.65 mg/mL
      insoluble in H2O
  9. Carfilzomib (PR-171)
    A1933 Carfilzomib (PR-171)
     10 Citation
    中文名: 卡非佐米
    Target: Proteasome
    Summary: 蛋白酶体抑制剂
      ≥35.99 mg/mL
      insoluble in H2O
  10. Bortezomib (PS-341)
    A2614 Bortezomib (PS-341)
     24 Citation
    中文名: 硼替佐米
    Target: Proteasome
    Summary: 蛋白酶体抑制剂
      ≥19.21 mg/mL
      insoluble in H2O

19件产品中的 1-10

页面
每页